No Detail Found!

Drug repositioning, an approach for identification of new therapeutics

Author(s)
Shaheen Yaseen Institute of Biochemistry And Biotechnology, University of The Punjab, Lahore, Pakistan.
Saima Akram Institute 0f Biochemistry And Biotechnology, University Oof The Punjab, Lahore, Pakistan.
Abstract
Drug repositioning of FDA approved drugs is an innovation stream of drug discovery. This review elaborates the advantages, approaches and challenges of drug repositioning. This low cost, less risky and less time consuming drug repositioning includes effective computational and experimental approaches to identify new indications for existing drugs. Similar to drug discovery, there are various challenges to repurpose a drug such as selection of an appropriate approach and target population, intellectual property (IP) protection and etc. This review also focuses on history and success stories of drug repositioning. An alternative approach, drug combination of two or multiple drugs has dramatically increased the success rate of drug repositioning. This synergistic drug repositioning is a promising strategy to combat various diseases such as infectious diseases, cancer, neurological disorders and many rare diseases. Various examples of successful synergistic drug repositioning have been described in this review. Finally, we can say that synergistic drug repositioning provides a new way to drug discovery research.
Publication Details
Page(s) 192-200
DOI DOI not available
Published Journal: Journal of Natural & Applied Sciences Pakistan, Volume: 1, Issue: 2, Year: 2019

Request the full text from PASTIC

Keywords
Drug repurposing, Drug repositioning, experimental approach, drug re PROFILING, computational approach, de novo drug discovery, synergistic drug repositioning
References
Ai N,Wood RD,Welsh WJ .2015 .Identification of nitazoxanide as a group imetabotropic glutamate receptor negative modulator for the treatment of neuropathic pain: an in silico drug repositioning study. Pharm Res, 32 : 2798-807.
Alfedi G. .2019 ."Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia." Movement Disorders. , : .
Amelio I,Gostev M,Knight RA,Willis AE,Melino G,Antonov AV .2014 .DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information. Cell Death Dis, 5 : e1051.
Ashburn ,K. B. Thor .2004 ."Drug repositioning: identifying and developing new uses for existing drugs. " Nat Rev Drug Discov, 3(8) : 673-683.
Brueggeman L. .2019 ."Drug repositioning in epilepsy reveals novel antiseizure candidates. " Ann Clin Transl Neurol, 6(2) : 295-309.
Jain Deotarse P. P.,Baile. M. B A. S.1 .2015 .Drug repositioning: a review. Int J Pharma Res Rev, 4 : 51-58.
de Mello C. P. P. .2018 ."Zika virus replication is substantially inhibited by novel favipiravir and interferon alpha combination regimens. " Antimicrob Agents Chemother, 62(1) : e01983-01917.
Fleisher GR,Wilmott CM,Campos JM .1983 .Amoxicillin combined with clavulanic acid for the treatment of soft tissue infections in children. Antimicrob Agents Chemother, 24 : 679-681.
Gerits E.,Defraine V.,Vandamme K.,De Cremer K.,De Brucker K.,Thevissen K. .2017 .Repurposing toremifene for treatment of oral bacterial infections. Antimicrob. Agents Chemother, 10 : 16-e1816.
Gns H. S. .2019 ."An update on Drug Repurposing: Re-written saga of the drug's fate.". Biomed Pharmacother, 110 : 700-716.
Graziano TS,Cuzzullin MC,Franco GC .2015 .Statins and antimicrobial effects: simvastatin as a potential drug against Staphylococcus aureus biofilm. PLOS ONE, 012 : 8098.
Han K. .2017 ."Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.". Nat Biotechnol, 35(5) : 463.
Houang ET,Watson C,Howell R,Chapman M .1984 .Ampicillin combined with sulbactam or metronidazole for single-dose chemoprophylaxis in major gynaecological surgery. J Antimicrob Chemother, 14 : 529-535.
KalantarMotamedi Y. .2018 ."A systematic and prospectively validated approach for identifying synergistic drug combinations against malaria.". Malar J, 17(1) : 160.
Kola I.,Landis J. .2004 .Can the pharmaceutical industry reduce attrition rates? Nat. , 3 : 711-715.
Kondo T. .2017 ."iPSC-based compound screening and in vitro trials identify a synergistic anti-amyloid β combination for Alzheimer's disease. " Cell Rep, 21(8) : 2304-2312.
Kulesa A. .2018 ."Combinatorial drug discovery in nanoliter droplets. " Proceedings of the National Academy of Sciences, 115(26) : 6685-6690.
Lee H,Kang S,Kim W. .2016 .Drug repositioning for cancer therapy based on large-scale druginduced transcriptional signatures. PloS ONE, 11 : e0150460.
Low Y. S. .2016 ."Synergistic drug combinations from electronic health records and gene expression. " Journal of the American Medical Informatics Association, 24(3) : 565-576.
Luo H. .2018 ."Computational drug repositioning with random walk on a heterogeneous network.". IEEE/ACM Trans Comput Biol Bioinform., : .
Medina-Franco J. L. .2013 ."Shifting from the single to the multitarget paradigm in drug discovery. " Drug Discov Today, 18(9) : 495-501.
Jafari Mohammad,R. Mohammad .2018 ."Drug Repositioning: A Review.". Journal of Iranian Medical Council, 1(1) : 7-10.
Naylor D. M. .2015 ."Therapeutic drug repurposing. repositioning and rescue." Drug Discovery: 57., : .
Ng S. M. S. .2018 ."Repurposing Zidovudine in combination with Tigecycline for treating carbapenemresistant Enterobacteriaceae infections.". European Journal of Clinical Microbiology & Infectious Diseases, 37(1) : 141-148.
Nilubol N. .2018 ."Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response. " Oncotarget, 9(68) : 33030.
Novac N. .2013 ."Challenges and opportunities of drug repositioning. " Trends Pharmacol Sci, 34(5) : 267-272.
Nygren P,Fryknas M,Agerup B .2013 .Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer. J Cancer Res Clin Oncol, 139(12) : 2133-40.
Pei F. .2017 ."Connecting neuronal cell protective pathways and drug combinations in a Huntington's Disease model through the application of quantitative systems pharmacology. " Sci Rep, 7(1) : 17803.
Pessetto ZY,Weir SJ,Sethi G .2013 .Drug repurposing for gastrointestinal stromal tumor. Mol Cancer Ther, 12(7) : 1299-309.
Qin X,Tran BG,Kim MJ,Wang L,Nguyen DA,Chen Q .2017 .A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intraabdominal infections in hospitalised adults in Asia. Int J Antimicrob Agents, : .
Serafin M. B.,Horner R. .2018 ."Drug repositioning, a new alternative in infectious diseases.". Braz J Infect Dis, 22(3) : 252-256.
Sertkaya A,Birkenbach A,Berlind A,Eyraud J .2014 .Examination of clinical trial costs and barriers for drug development. US Department of health and human services, office of the assistant secretary for planning and evaluation report. , 1 : 1-92.
Matthews S.J.,Mccoy C. .2018 .Thalidomide-AReview-of-Approved-andinvestigationaluses. , : .
Snyder B. .2018 ."Synergistic antiviral activity of Sofosbuvir and type‐I interferons (α and β) against Zika virus. " Journal of medical virology 90, (1) : 8-12.
Stathias V. .2018 ."Drug and disease signature integration identifies synergistic combinations in glioblastoma.". Nat Commun, 9(1) : 5315.
Stenvang J,Kumler I,Nygard SB .2013 .Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development. Front Oncol, 3 : 313.
Sun W. .2017 ."Synergistic drug combination effectively blocks Ebola virus infection. " Antiviral Res, 137 : 165-172.
Sun W. .2016 ."Drug combination therapy increases successful drug repositioning. " Drug Discov Today, 21(7) : 1189-1195.
Tran T. B. .2018 ."Novel polymyxin combination with antineoplastic mitotane improved the bacterial killing against polymyxin-resistant multidrug-resistant gram-negative pathogens. " Front Microbiol, 9 : 721.
Xu H. .2014 ."Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality. " Journal of the American Medical Informatics Association, 22(1) : 179-191.
Yeu Y,Yoon Y,Park S Y .2015 .Protein localization vector propagation: a method for improving the accuracy of drug repositioning. Mol Biosyst, 11(7) : 2096-102.
Shi Y.,Inoue H.,Wu J.C.,S. J.C. .2016 .YamanakaInduced pluripotent stem cell technology: a decade of progress Nat. Rev. Drug Discov, 16 : 115-130.
Zilberberg MD,Shorr AF,Micek ST,VazquezGuillamet C,Kollef MH .2014 .Multidrug resistance, inappropriate initial antibiotic therapy and mortality in Gramnegative severe sepsis and septic shock: a retrospective cohort study. Crit Care, 18 : 596.
0

Citations

0

Downloads

72

Views